Matthew Davis
Podiatrist · Waynesville, NCNPI 1356599096
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,415 of the $1,652 with a category attached, or 85.7%. It is spread thinly across 22 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $581 and has fallen 65.2% since, to $202 in 2025. That places this record below the midpoint for podiatrist clinicians in NC, where the typical reported total is $1,989.
Across 68 payments — averaging $24.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$302
- Smith+Nephew$278
- Paratek Pharmaceuticals, Inc.$206
- AbbVie$170
- Treace Medical Concepts, Inc.$152
- Fusion Orthopedics USA, LLC$114
- plus $429 from 16 others
What the payments were for
- Travel & lodging$1529%
- Food & beverage$1,41586%
- Education$855%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 10 | $302 |
| Smith+Nephew | 13 | $278 |
| Paratek Pharmaceuticals, Inc. | 10 | $206 |
| AbbVie(2 entities) | 12 | $170 |
| Treace Medical Concepts, Inc. | 1 | $152 |
| Fusion Orthopedics USA, LLC | 1 | $114 |
| Rikco International, LLC | 2 | $85 |
| Averitas Pharma Inc. | 4 | $79 |
| Advanced Oxygen Therapy Inc. | 2 | $35 |
| GRT US Holding, Inc. | 1 | $25 |
| Abbott | 1 | $20 |
| Zimmer Biomet | 1 | $20 |
| KCI USA, Inc. | 1 | $20 |
| Linvatec Corporation | 1 | $20 |
| Convatec Inc. | 1 | $18 |
| Stryker | 1 | $17 |
| Paragon 28, Inc. | 1 | $17 |
| Medtronic | 1 | $16 |
| In2bones USA, LLC | 1 | $16 |
| Smoky Mountain Surgical LLC | 1 | $15 |
| Mimedx Group, Inc. | 1 | $14 |
| Bioventus LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,652 in reported general payments places this provider in the 45th percentile of 109 podiatrist providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| QutenzaCapsaicin/Skin Cleanser | 17 | $60,571 |
| Ketoconazole | 48 | $1,467 |
| Ciclopirox | 41 | $766 |
| Methylprednisolone | 109 | $558 |
| Terbinafine Hcl | 40 | $518 |
| Gabapentin | 50 | $475 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 50 | $399 |
| Doxycycline Hyclate | 62 | $380 |
| Pregabalin | 19 | $377 |
| Allopurinol | 18 | $227 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 62 | $225 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 25 | $206 |
| Mupirocin | 24 | $173 |
| Colchicine | 13 | $169 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $125 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GRT US Holding, Inc.Qutenza | $25 | $60,57117 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 109 podiatrist providers in North Carolina.
Other podiatrist in Waynesville
- Robert PrzynoschWaynesville$9K
- William BanksWaynesville$9K
- Robert DelbeneWaynesville$3K
- Jordan MeyersRaleigh$343K
- Christopher GaulandGreenville$56K
- Scott MartinRocky Mount$14K
- Gretchen LawrenceForest City$12K
- William WeilyCharlotte$11K
- Kristin KirbyHuntersville$10K
- Emily LobosAsheville$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.